| 000 | 01280 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250518080118.0 | ||
| 264 | 0 | _c20200325 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1942-5546 | ||
| 024 | 7 |
_a10.1016/j.mayocp.2019.11.013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRajkumar, S Vincent | |
| 245 | 0 | 0 |
_aThe High Cost of Insulin in the United States: An Urgent Call to Action. _h[electronic resource] |
| 260 |
_bMayo Clinic proceedings _c01 2020 |
||
| 300 |
_a22-28 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aCosts and Cost Analysis |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xdrug therapy |
| 650 | 0 | 4 |
_aDrug Industry _xeconomics |
| 650 | 0 | 4 |
_aDrug and Narcotic Control _xmethods |
| 650 | 0 | 4 |
_aHealth Services Accessibility _xstandards |
| 650 | 0 | 4 |
_aHealth Services Needs and Demand _xorganization & administration |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xeconomics |
| 650 | 0 | 4 |
_aInsulin _xeconomics |
| 650 | 0 | 4 |
_aMedication Therapy Management _xeconomics |
| 650 | 0 | 4 |
_aPrescription Fees _xstandards |
| 650 | 0 | 4 | _aUnited States |
| 773 | 0 |
_tMayo Clinic proceedings _gvol. 95 _gno. 1 _gp. 22-28 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.mayocp.2019.11.013 _zAvailable from publisher's website |
| 999 |
_c30484367 _d30484367 |
||